New immunofluorescence assays for detection of human herpesvirus 8-specific antibodies

被引:18
作者
Inoue, N
Mar, EC
Dollard, SC
Pau, CP
Zheng, Q
Pellett, PE
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Atlanta, GA 30333 USA
[2] Ctr Dis Control & Prevent, Natl Ctr Infect Dis, Div AIDS STD & TB Lab Res, Atlanta, GA 30333 USA
关键词
D O I
10.1128/CDLI.7.3.427-435.2000
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Several assays have been developed for detection of immunoglobulin G antibodies to Human herpesvirus 8 (HHV-8), including immunofluorescence assays (IFAs) and enzyme-linked immunosorbent assays (ELISAs), However, the specificity and sensitivity of these assays are not completely defined due to the lack of a "gold standard." Although IFAs based on primary effusion lymphoma (PEL) cell lines are used widely, the assays can be confounded by nonspecific reactions against cellular components and potential cross-reaction with anti bodies against other herpesviruses. To provide more reliable IFAs, we established recombinant Semliki Forest viruses (rSFVs) expressing the HHV-8-specific proteins ORF73 and K8.1 and used BHK-21 cells infected with these rSFVs For IFA (ORF73-IFA and K8.1-IFA), Expression of the HHV-8-specific proteins at very high levels by the rSFV system allowed easy scoring for IFA and thereby increased specificity, The rSFV system also allowed detection of antibodies against glycosylation-dependent epitopes of K8.1. Titers measured by rSFV-based IFAs and PEL-based IFAs correlated well (correlation coefficients of >0.9), and concordances of seroreactivities between rSFV-based and PEL-based IFAs were >97% (kappa > 0.93). K8.1-IFA was more sensitive than either ORF73-IFA or peptide ELISAs. Using PEL-based lytic IFA as a reference assay, the sensitivity and specificity of K8.1-IFA were estimated to be 94 and 100%, respectively. HHV-8 prevalences determined by K8.1-IFA among the human immunodeficiency virus (HIV)-positive (HIV+) Kaposi's sarcoma (KS) patients, HIV+ KS- patients, and healthy controls were 100, 65, and 6.7%, respectively, which were consistent with prior reports. Therefore, our rSFV based IFAs may provide a specific and sensitive method for use in epidemiology studies. in addition, they will provide a basis for further development of diagnostic tests for HHV-8 infection.
引用
收藏
页码:427 / 435
页数:9
相关论文
共 39 条
[1]   Detection of antibodies against viral capsid proteins of human herpesvirus 8 in AIDS-associated Kaposi's sarcoma [J].
Andre, S ;
Schatz, O ;
Bogner, JR ;
Zeichhardt, H ;
StofflerMeilicke, M ;
Jahn, HU ;
Ullrich, R ;
Sonntag, AK ;
Kehm, R ;
Haas, J .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (02) :145-152
[2]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644
[3]   Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity [J].
Bouche, F ;
Ammerlaan, W ;
Berthet, F ;
Houard, S ;
Schneider, F ;
Muller, CP .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (03) :721-726
[4]   Serologic evidence for mother-to-child transmission of Kaposi sarcoma-associated herpesvirus infection [J].
Bourboulia, D ;
Whitby, D ;
Boshoff, C ;
Newton, R ;
Beral, V ;
Carrara, H ;
Lane, A ;
Sitas, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (01) :31-32
[5]   IN-VITRO ESTABLISHMENT AND CHARACTERIZATION OF 2 ACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED LYMPHOMA CELL-LINES (BC-1 AND BC-2) CONTAINING KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE (KSHV) DNA-SEQUENCES [J].
CESARMAN, E ;
MOORE, PS ;
RAO, PH ;
INGHIRAMI, G ;
KNOWLES, DM ;
CHANG, Y .
BLOOD, 1995, 86 (07) :2708-2714
[6]   Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glycoproteins generated by spliced transcripts [J].
Chandran, B ;
Bloomer, C ;
Chan, SR ;
Zhu, LJ ;
Goldstein, E ;
Horvat, R .
VIROLOGY, 1998, 249 (01) :140-149
[7]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[8]   Seroepidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV) [J].
Chatlynne, LG ;
Ablashi, DV .
SEMINARS IN CANCER BIOLOGY, 1999, 9 (03) :175-185
[9]   Detection and titration of human herpesvirus-8-specific antibodies in sera from blood donors, acquired immunodeficiency syndrome patients and Kaposi's sarcoma patients using a whole virus enzyme-linked immunosorbent assay [J].
Chatlynne, LG ;
Lapps, W ;
Handy, M ;
Huang, YO ;
Masood, R ;
Hamilton, AS ;
Said, JW ;
Koeffler, HP ;
Kaplan, MH ;
Friedman-Kien, A ;
Gill, PS ;
Whitman, JE ;
Ablashi, DV .
BLOOD, 1998, 92 (01) :53-58
[10]   Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide [J].
Davis, DA ;
Humphrey, RW ;
Newcomb, FM ;
OBrien, TR ;
Goedert, JJ ;
Straus, SE ;
Yarchoan, R .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (05) :1071-1079